At a median follow-up of 1.5 years, promising data from the 320 mg expansion cohort of phase 1/1b study shows no progression in patients with treatment-naïve CLL treated with sonrotoclax, a ...

This important study describes a first-in-human trial of autologous p63+ stem cells in patients with idiopathic pulmonary fibrosis, a lethal condition for which effective treatments are lacking. The ...

A look at news events in June 2024. 1 - Israel's government says its conditions for ending the war with Hamas have not ...

Progression-free survival was superior with first-line maintenance of palbociclib in HR-positive, HER2-positive metastatic ...

Welcome to the Tuesday edition of the Pick Six newsletter! The Bengals and Cowboys might not be playoff contenders, but they ...

With the San Francisco 49ers fighting to avoid playoff elimination in the final stretch of the regular season, it's also time ...

Brexucabtagene autoleucel showed comparable efficacy outcomes in patients aged 60 to 69 with relapsed/refractory B-cell acute ...

Industry-wide lithium mine capacity reductions since the end of 2023 are estimated to lower lithium supplies by about 14% in ...

LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial ...

Minkah Fitzpatrick is aware of the narrative that he doesn't make many splash plays anymore, let alone create turnovers, so the Pittsburgh Steelers' three-time All-Pro free safety must be ...

New York Yankees slugging outfield prospect Spencer Jones remains an enormous man. Unfortunately, according to Baseball ...